Lawrence Lamb
2021
In 2021, Lawrence Lamb earned a total compensation of $918.8K as Executive Vice President, Chief Scientific Officer at IN8BIO, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,450 |
|---|---|
| Option Awards | $436,281 |
| Salary | $326,023 |
| Total | $918,754 |
Lamb received $436.3K in option awards, accounting for 47% of the total pay in 2021.
Lamb also received $156.5K in non-equity incentive plan and $326K in salary.
Rankings
In 2021, Lawrence Lamb's compensation ranked 9,060th out of 12,415 executives tracked by ExecPay. In other words, Lamb earned more than 27.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,060 out of 12,415 | 27th |
Division Manufacturing | 4,023 out of 5,505 | 27th |
Major group Chemicals And Allied Products | 1,769 out of 2,375 | 26th |
Industry group Drugs | 1,574 out of 2,096 | 25th |
Industry Biological Products, Except Diagnostic Substances | 343 out of 449 | 24th |
Source: SEC filing on April 22, 2022.
Lamb's colleagues
We found two more compensation records of executives who worked with Lawrence Lamb at IN8BIO in 2021.